Big Pharma Sharma

Home
Notes
Chat
Pricing
About BPS
Document Library
Sponsored Posts
Free Posts
Archive

ASH Part 2: Anito-cel is off to the races, but will it be fast enough to catch-up to Cilta-cel?

READ THE LATEST
ASH 2024 | Part 1: Miltenyi and Galapagos Aim Big in CAR-T, but Gaps Remain
It’s time for the annual ASH meeting, always a showcase for cutting-edge clinical data in competitive areas like blood cancers and hemoglobinopathies.
 • 
Big Pharma Sharma
Two things I think coming out of SITC 2024
SITC 2024 brought forward some fascinating data, highlighting both the strides we’re making in immuno-oncology and the hurdles that remain.
 • 
Big Pharma Sharma
Flipping the Script on Failed Immuno-Oncology Targets: The Case for “Inverse-I/O” in Autoimmune Diseases
Since the success of PD-(L)1 therapies, immuno-oncology (I/O) has been a hotbed of activity, with companies scrambling to find the next blockbuster…
 • 
Big Pharma Sharma
Priority Review Voucher (PRV) Market Update – Big Pharma Unloading its Ammo
Refreshing my PRV tracker database and providing you with the latest analysis of this interesting market
 • 
Big Pharma Sharma
TIGIT: Too Legit to Quit? Or Just Can't Hit?
Let's take a look at the controversial TIGIT landscape, what we know, and when we will know whether TIGIT is here to stay or not
 • 
Big Pharma Sharma
1
Three Major Implications Coming out of ESMO 2024
Three big strategic implications from three-ish data readouts we saw at ESMO
 • 
Big Pharma Sharma
What the Ivonescimab Data at WCLC Tells Us About China's Role in Drug Development
Below I get into my quick thoughts about the ivonescimab HARMONi-2 data and our need to change our view on ex-US/EU data readouts.
 • 
Big Pharma Sharma
Big Pharma Sharma
Big Pharma Sharma
12+ year BioPharma strategy pro, facetiously named "Big Pharma Sharma". Delivering weekly insights, analyses, and takes here from an insider's perspective.
Recommendations
Matt Gamber’s Biotech Newsletter
Matt Gamber
BowTiedBiotech
BowTiedBiotech
BowTiedBiotech
Cell and Gene Therapy Today
Pedro Silva Couto
Cell & Gene weekly
Marco Sabatini
Twitter
Follow me on Twitter/X!
LinkedIn
Follow me on LinkedIn!

Big Pharma Sharma

AboutArchiveRecommendationsSitemap
© 2024 Big Pharma Sharma, LLC
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture